A novel heart failure mice model of hypertensive heart disease by angiotensin II infusion, nephrectomy, and salt loading.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  American Journal of Physiology. Heart and Circulatory Physiology

• Publication date

  2013-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1152/ajpheart.00349.2013PMID 24043257
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fibrosis and heart failure

  2014cited by this paper
• Interleukin-16 Promotes Cardiac Fibrosis and Myocardial Stiffening in Heart Failure with Preserved Ejection Fraction

  2013cited by this paper
• L-Carnitine prevents the development of ventricular fibrosis and heart failure with preserved ejection fraction in hypertensive heart disease

  2012cited by this paper
• Variable phenotype in murine transverse aortic constriction.

  2012cited by this paper
• Can we predict which patients will evolve to chronic kidney disease after nephrectomy for cortical renal tumors?

  2012cited by this paper
• Long-Term Consequences of Uninephrectomy in Male and Female Rats

  2012cited by this paper
• Animal models of heart failure: a scientific statement from the American Heart Association.

  2012cited by this paper
• Lack of microsomal prostaglandin E synthase-1 reduces cardiac function following angiotensin II infusion.

  2011cited by this paper
• Balloon type elasticity sensing for left ventricle of small laboratory animal

  2011cited by this paper
• Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathway.

  2011cited by this paper
• Oxidative stress and heart failure.

  2011cited by this paper
• Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model.

  2010cited by this paper
• Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy.

  2010cited by this paper
• Cardiac mast cells cause atrial fibrillation through PDGF-A-mediated fibrosis in pressure-overloaded mouse hearts.

  2010cited by this paper
• Relationship between renal function and heart failure in hypertensive patients

  2010cited by this paper
• Regulatory mechanism of length-dependent activation in skinned porcine ventricular muscle: role of thin filament cooperative activation in the Frank-Starling relation

  2010cited by this paper
• C-Reactive Protein Promotes Cardiac Fibrosis and Inflammation in Angiotensin II-Induced Hypertensive Cardiac Disease

  2010cited by this paper
• Cardiac steroidogenesis and glucocorticoid in the development of cardiac hypertrophy during the progression to heart failure

  2009cited by this paper
• Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity.

  2009cited by this paper
• The I&kgr;B Kinase β/Nuclear Factor &kgr;B Signaling Pathway Protects the Heart From Hemodynamic Stress Mediated by the Regulation of Manganese Superoxide Dismutase Expression

  2009cited by this paper
• Rac1 Is Required for Cardiomyocyte Apoptosis During Hyperglycemia

  2009cited by this paper
• Strain vessel hypothesis: a viewpoint for linkage of albuminuria and cerebro-cardiovascular risk

  2009cited by this paper
• Small animal models of heart failure: development of novel therapies, past and present.

  2009cited by this paper
• Renal interactions of renin-angiotensin system, nitric oxide and superoxide anion: implications in the pathophysiology of salt-sensitivity and hypertension.

  2009cited by this paper
• Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies

  2009cited by this paper
• The IκB Kinase β/Nuclear Factor κB Signaling Pathway Protects the Heart From Hemodynamic Stress Mediated by the Regulation of Manganese Superoxide Dismutase Expression

  2009cited by this paper
• Measurement of cardiac function using pressure–volume conductance catheter technique in mice and rats

  2008cited by this paper
• Pravastatin Attenuates Left Ventricular Remodeling and Diastolic Dysfunction in Angiotensin II-Induced Hypertensive Mice

  2008cited by this paper
• Downregulation of ferritin heavy chain increases labile iron pool, oxidative stress and cell death in cardiomyocytes.

  2008cited by this paper
• Partial nephrectomy as a model for uremic cardiomyopathy in the mouse.

  2008cited by this paper
• Plasma creatinine determination in mice and rats: an enzymatic method compares favorably with a high-performance liquid chromatography assay.

  2007cited by this paper
• Uninephrectomy in Young Age or Chronic Salt Loading Causes Salt-Sensitive Hypertension in Adult Rats

  2007cited by this paper
• Molecular signaling mediated by angiotensin II type 1A receptor blockade leading to attenuation of renal dysfunction-associated heart failure.

  2007cited by this paper
• Elevated cardiac tissue level of aldosterone and mineralocorticoid receptor in diastolic heart failure: Beneficial effects of mineralocorticoid receptor blocker.

  2007cited by this paper
• Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study.

  2006cited by this paper
• [Oxidative stress and heart failure].

  2006cited by this paper
• Senescence-associated phenotypes in Akita diabetic mice are enhanced by absence of bradykinin B2 receptors.

  2006cited by this paper
• Cardiac-Specific Deletion of Gata4 Reveals Its Requirement for Hypertrophy, Compensation, and Myocyte Viability

  2006cited by this paper
• Association of RhoGDIalpha with Rac1 GTPase mediates free radical production during myocardial hypertrophy.

  2006cited by this paper
• Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

  2004cited by this paper
• Increased Collagen Type I Synthesis in Patients With Heart Failure of Hypertensive Origin: Relation to Myocardial Fibrosis

  2004cited by this paper
• Oxidative stress in heart failure. More than just damage.

  2003cited by this paper
• Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart.

  2002cited by this paper
• Ventricular expression of natriuretic peptides in Npr1(-/-) mice with cardiac hypertrophy and fibrosis.

  2002cited by this paper
• Echocardiographic assessment of LV hypertrophy and function in aortic-banded mice: necropsy validation.

  2002cited by this paper
• Load Versus Humoral Activation in the Genesis of Early Hypertensive Heart Disease

  2001cited by this paper
• Ventricular production of natriuretic peptides and ventricular structural remodeling in hypertensive heart failure

  2001cited by this paper
• Local neurohumoral regulation in the transition to isolated diastolic heart failure in hypertensive heart disease: absence of AT1 receptor downregulation and 'overdrive' of the endothelin system.

  2000cited by this paper
• Development of different phenotypes of hypertensive heart failure: systolic versus diastolic failure in Dahl salt‐sensitive rats

  2000cited by this paper
• Sodium induces hypertrophy of cultured myocardial myoblasts and vascular smooth muscle cells.

  1998cited by this paper
• Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride: a meta-analysis.

  1998cited by this paper
• Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats.

  1996cited by this paper
• Oxygen free radicals and congestive heart failure.

  1991cited by this paper
• Compensatory hypertrophy and failure in gradual pressure-overloaded guinea pig heart.

  1989cited by this paper
• Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat.

  1982cited by this paper

• Lack of ALCAT1 enhances the protective effects of aerobic exercise on kidney in HFpEF mice.

  2025cites this paper
• The 3D World of Spheroids: Searching for an Optimal Method of Fabricating Pro-Reparative Cardiospheres

  2025cites this paper
• Cardiomyocyte Rac1 signaling in hypertrophy, arrhythmia, and cardiac stress adaptation

  2025cites this paper
• Angiotensin II induces sex-specific ventricular remodeling in aging C57Bl/6 mice.

  2025cites this paper
• Echocardiographic Assessment of Cardiac Function in Mouse Models of Heart Disease

  2025cites this paper
• Cardiovascular, Kidney, Liver, and Metabolic Interactions in Heart Failure: Breaking Down Silos

  2025cites this paper
• Distinguishing pathophysiological features of heart failure with reduced and preserved ejection fraction: A comparative analysis of two mouse models.

  2024cites this paper
• SARS-CoV-2 pathogenesis in an angiotensin II–induced heart-on-a-chip disease model and extracellular vesicle screening

  2024cites this paper
• PDE4D mediates impaired β-adrenergic receptor signaling in the sinoatrial node in mice with hypertensive heart disease.

  2023cites this paper
• Cardiorenal damages in mice at early phase after intervention induced by angiotensin II, nephrectomy, and salt intake

  2023cites this paper
• An In Vitro Platform to Study Reversible Endothelial-to-Mesenchymal Transition

  2022cites this paper
• Telomere Shortening in Hypertensive Heart Disease Depends on Oxidative DNA Damage and Predicts Impaired Recovery of Cardiac Function in Heart Failure

  2022cites this paper
• Mimicking Metabolic Disturbance in Establishing Animal Models of Heart Failure With Preserved Ejection Fraction

  2022cites this paper
• A systematic review and meta-analysis of murine models of uremic cardiomyopathy.

  2021influential citation
• Toward the Effective Bioengineering of a Pathological Tissue for Cardiovascular Disease Modeling: Old Strategies and New Frontiers for Prevention, Diagnosis, and Therapy

  2021cites this paper
• Histamine receptor agonist alleviates severe cardiorenal damages by eliciting anti-inflammatory programming

  2020influential citation
• Mouse Models of Heart Failure with Preserved or Reduced Ejection Fraction.

  2020cites this paper
• Histamine provides an original vista on cardiorenal syndrome

  2020cites this paper
• Temporal Expression and Cellular Localization of PAPPA2 in the Developing Kidney of Rat

  2020cites this paper
• Experimental models of cardiac physiology and pathology

  2019cites this paper
• Relation of Dietary Sodium Intake With Subclinical Markers of Cardiovascular Disease (from MESA).

  2019cites this paper
• Ghrelin protects the myocardium with hypoxia/reoxygenation treatment through upregulating the expression of growth hormone, growth hormone secretagogue receptor and insulin-like growth factor-1, and promoting the phosphorylation of protein kinase B

  2018cites this paper
• Cardiovascular Interactions between Fibroblast Growth Factor-23 and Angiotensin II

  2018cites this paper
• SUMOylation of the B2AR influences receptor internalisation, desensitisation and downstream signalling

  2017cites this paper
• The renal–cardiac connection in subjects with preserved ejection fraction: a population based study

  2017cites this paper
• Role of Kidneys in Sex Differences in Angiotensin II–Induced Hypertension

  2017cites this paper
• Nephron number, hypertension, and CKD: physiological and genetic insight from humans and animal models.

  2017cites this paper
• Recruitment of macrophages from the spleen contributes to myocardial fibrosis and hypertension induced by angiotensin II

  2017cites this paper
• Essential Role for Premature Senescence of Myofibroblasts in Myocardial Fibrosis.

  2016cites this paper
• Possible role for brain prostanoid pathways in the development of angiotensin II-salt hypertension in rats.

  2016cites this paper
• Mitochondria in Disease Combination of angiotensin II and L - N G -nitroarginine methyl ester exacerbates mitochondrial dysfunction and oxidative stress to cause heart failure

  2016cites this paper
• Cardiovascular Mitochondria and Redox Control in Health and Disease Combination of angiotensin II and LN G-nitroarginine methyl ester exacerbates mitochondrial dysfunction and oxidative stress to cause heart failure

  2016cites this paper
• Investigating Angiotensin II in cardiac remodelling and the counter-regulatory actions of Angiotensin-(1-9)

  2016cites this paper
• Combination of angiotensin II and l-NG-nitroarginine methyl ester exacerbates mitochondrial dysfunction and oxidative stress to cause heart failure.

  2016cites this paper
• Models to Investigate Cardiac Metabolism

  2016cites this paper
• Remodelling of the Cardiac Extracellular Matrix: Role of Collagen Degradation and Accumulation in Pathogenesis of Heart Failure

  2015cites this paper
• Extracellular matrix communication and turnover in cardiac physiology and pathology.

  2015cites this paper
• Possible prevention of dialysis-requiring congestive heart failure by angiotensin-II receptor blockers in non-dialysis Japanese patients with Stage 5 chronic kidney disease

  2015cites this paper
• Augmented Rac1 Expression and Activity are Associated with Oxidative Stress and Decline of β Cell Function in Obesity

  2015cites this paper
• Rac-1 as a new therapeutic target in cerebro- and cardio-vascular diseases.

  2014cites this paper
• The Role of Nrf2-Mediated Pathway in Cardiac Remodeling and Heart Failure

  2014cites this paper
• Exendin-4 alleviates angiotensin II-induced senescence in vascular smooth muscle cells by inhibiting Rac1 activation via a cAMP/PKA-dependent pathway.

  2014cites this paper
• Investigating the role and regulation of the AMPK-related kinase NUAK1

  2013cites this paper